PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer

NCT02793856 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: Cyclophosphamide
OTHER: PD-1 Knockout T Cells

Sponsor

Sichuan University

Collaborators

[object Object]